Bio-Rad Investor Accuses Board Of Rampant Malfeasance

Law360, Wilmington (August 18, 2015, 9:59 PM EDT) -- A Bio-Rad Laboratories Inc. institutional investor accused the lab-equipment giant's board on Tuesday of letting the company "careen out of control" before a $55 million foreign-bribery settlement with federal agencies, and covering up rampant misconduct that its law firm didn't catch.

The U.S. Department of Justice and U.S. Securities and Exchange Commission had hit Bio-Rad with foreign bribery charges in November as part of a $55 million settlement to resolve claims centering on $7.5 million in improper payments to Russian, Vietnamese and Thai officials. The company self-reported its misconduct and entered into a nonprosecution agreement.

All of the activity that caused...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!